Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101489648 | 10148964 | 8 | F | 2013 | 20160803 | 20140502 | 20160808 | EXP | US-AMGEN-USASP2014031409 | AMGEN | 71.00 | YR | E | M | Y | 0.00000 | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101489648 | 10148964 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, 2 TIMES/WK | U | 1038223 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW | ||||
| 101489648 | 10148964 | 2 | SS | ENBREL | ETANERCEPT | 1 | U | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||||
| 101489648 | 10148964 | 3 | SS | ENBREL | ETANERCEPT | 1 | U | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101489648 | 10148964 | 1 | Psoriatic arthropathy |
| 101489648 | 10148964 | 2 | Psoriasis |
| 101489648 | 10148964 | 3 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101489648 | 10148964 | OT |
| 101489648 | 10148964 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101489648 | 10148964 | Aortic valve replacement | |
| 101489648 | 10148964 | Arthralgia | |
| 101489648 | 10148964 | Drug effect incomplete | |
| 101489648 | 10148964 | Dysphagia | |
| 101489648 | 10148964 | Dyspnoea | |
| 101489648 | 10148964 | Musculoskeletal pain | |
| 101489648 | 10148964 | Musculoskeletal stiffness | |
| 101489648 | 10148964 | Neoplasm malignant | |
| 101489648 | 10148964 | Pain in extremity | |
| 101489648 | 10148964 | Peripheral swelling | |
| 101489648 | 10148964 | Poor peripheral circulation | |
| 101489648 | 10148964 | Psoriasis | |
| 101489648 | 10148964 | Psoriatic arthropathy | |
| 101489648 | 10148964 | Sciatica | |
| 101489648 | 10148964 | Speech disorder | |
| 101489648 | 10148964 | Spinal decompression | |
| 101489648 | 10148964 | Spinal fusion surgery | |
| 101489648 | 10148964 | Therapeutic response decreased | |
| 101489648 | 10148964 | Tracheostomy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101489648 | 10148964 | 1 | 20100101 | 0 |